177 related articles for article (PubMed ID: 28481707)
1. Immune Checkpoint Blockade in Metastatic Urothelial Cancer.
Balar AV
J Clin Oncol; 2017 Jul; 35(19):2109-2112. PubMed ID: 28481707
[TBL] [Abstract][Full Text] [Related]
2. Targeted Therapy for Metastatic Urothelial Cancer: A Work in Progress.
Plimack ER; Geynisman DM
J Clin Oncol; 2016 Jun; 34(18):2088-92. PubMed ID: 27161964
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for Muscle-Invasive Bladder Cancer: Better Late Than Never?
Sonpavde G; Gordetsky JB; Lockhart ME; Nix JW
J Clin Oncol; 2016 Mar; 34(8):780-5. PubMed ID: 26786922
[TBL] [Abstract][Full Text] [Related]
4. Definitive Management of Primary Bladder Tumors in the Context of Metastatic Disease: Who, How, When, and Why?
Galsky MD; Domingo-Domenech J; Sfakianos JP; Ferket BS
J Clin Oncol; 2016 Oct; 34(29):3495-3498. PubMed ID: 27551117
[TBL] [Abstract][Full Text] [Related]
5. Decision Making in a Data-Poor Environment: Management of Brain Metastases From Testicular and Extragonadal Germ Cell Tumors.
Gilligan T
J Clin Oncol; 2016 Feb; 34(4):303-6. PubMed ID: 26668343
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
7. Timing Is Everything: What Is the Optimal Duration After Chemoradiation for Surgery for Rectal Cancer?
Goodman KA
J Clin Oncol; 2016 Nov; 34(31):3724-3728. PubMed ID: 27601550
[TBL] [Abstract][Full Text] [Related]
8. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
[TBL] [Abstract][Full Text] [Related]
9. Duration of Anti-Programmed Death-1 Therapy in Advanced Melanoma: How Much of a Good Thing Is Enough?
Khushalani NI
J Clin Oncol; 2018 Jun; 36(17):1649-1653. PubMed ID: 29389234
[TBL] [Abstract][Full Text] [Related]
10. Concurrent Chemotherapy and Radiation Therapy for Inoperable Locally Advanced Non-Small-Cell Lung Cancer.
Rosenzweig KE; Gomez JE
J Clin Oncol; 2017 Jan; 35(1):6-10. PubMed ID: 27870565
[TBL] [Abstract][Full Text] [Related]
11. Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC.
Millikan R; Dinney C; Swanson D; Sweeney P; Ro JY; Smith TL; Williams D; Logothetis C
J Clin Oncol; 2001 Oct; 19(20):4005-13. PubMed ID: 11600601
[TBL] [Abstract][Full Text] [Related]
12. The role of pelvic lymphadenectomy in non-muscle invasive bladder cancer.
Lin J; Deibert CM; Holder D; Benson MC; McKiernan JM
Can J Urol; 2014 Feb; 21(1):7108-13. PubMed ID: 24529010
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy for urothelial cancer of the bladder--update 2012].
Niegisch G; Lorch A; Albers P
Aktuelle Urol; 2012 Dec; 43(6):412-9. PubMed ID: 23196781
[TBL] [Abstract][Full Text] [Related]
14. Therapy for Muscle-Invasive Urothelial Carcinoma: Controversies and Dilemmas.
Sonpavde GP; Mouw KW; Mossanen M
J Clin Oncol; 2022 Apr; 40(12):1275-1280. PubMed ID: 35271295
[No Abstract] [Full Text] [Related]
15. Tumor regression grade of urothelial bladder cancer after neoadjuvant chemotherapy: a novel and successful strategy to predict survival.
Fleischmann A; Thalmann GN; Perren A; Seiler R
Am J Surg Pathol; 2014 Mar; 38(3):325-32. PubMed ID: 24525502
[TBL] [Abstract][Full Text] [Related]
16. Plasmacytoid variant of urothelial carcinoma: a report of a rare case.
Demellawy DE; Ahmed AD; Bora B; Bonin M
Pathol Res Pract; 2012 Sep; 208(9):561-4. PubMed ID: 22854197
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.
Calabrò F; Sternberg CN
Eur Urol; 2009 Feb; 55(2):348-58. PubMed ID: 18977070
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy is possibly beneficial for locally advanced or node-positive bladder cancer.
Kanatani A; Nakagawa T; Kawai T; Naito A; Sato Y; Yoshida K; Nozaki K; Nagata M; Yamada Y; Azuma T; Suzuki M; Fujimura T; Fukuhara H; Nishimatsu H; Kume H; Igawa Y; Homma Y
Clin Genitourin Cancer; 2015 Apr; 13(2):e107-12. PubMed ID: 25456839
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary Infiltrates in a Patient With Advanced Melanoma.
Powell CA
J Clin Oncol; 2017 Mar; 35(7):705-708. PubMed ID: 28029320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
